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Cardiac resynchronization therapy (CRT) has shown to
be an effective treatment for patients with advanced
heart failure (HF) (NYHA Class III or IV), reduced left
ventricular ejection fraction (LVEF \ 35%) and wide
QRS complexes ([120 ms) [1, 2]. The beneficial
effects include improvement in heart failure symp-
toms, exercise capacity, and left ventricular function,
as well as less heart failure hospitalizations and lower
mortality rates. Despite these remarkable results, 30–
40% of patients show no benefit after CRT, the
so-called ‘non-responders’ [3–5]. It remains, however,
difficult to distinguish responders from non-responders
in the early period after CRT. The presence of LV
dyssynchrony prior to implantation and its subsequent
reduction after implantation are proposed as the key
mechanisms for response to CRT [5, 6].
A variety of imaging modalities has already been
applied to identify dyssynchrony and to evaluate the
effects of CRT [7–10]. The use of echocardiography
[11–17], magnetic resonance imaging (MRI) [18–29],
and multislice computed tomography (MSCT) [30–
43] has recently been proven for patients eligible for
CRT. In addition, nuclear imaging techniques have
become suited for the evaluation of LV dyssynchrony
[44–51]. Until now, scintigraphic studies in CRT
mainly concerned radionuclide angiography with
phase image analysis [52–55]. In recent years posi-
tron emission tomography (PET) has emerged as a
suitable modality to study the metabolic mechanisms
of left ventricular dyssynchrony and the effects of
CRT [56]. It has been reported that dyssynchrony
influences regional myocardial workload, cardiac
efficiency and oxygen metabolism as measured by
carbon-11 (11C)-acetate PET. Several studies did
already report that 11C-acetate PET performed in the
chronic phase after CRT showed improvement of
oxygen metabolism and cardiac efficiency by CRT
[57, 58]. However, there are no data regarding the
value of 11C-acetate PET to predict responses to
CRT in the acute phase after treatment.
In the current issue in the International Journal of
Cardiovascular Imaging, Kitaizumi et al. [59] exam-
ined the usefulness of 11C-acetate PET for assessing
the early efficacy of CRT in 20 patients with severe
heart failure. All patients underwent 11C-acetate PET
imaging within 1 week after CRT. Oxygen consump-
tion was measured by the mono-exponential clear-
ance rate of 11C-acetate for both the patient’s own
beats (CRT off) and biventricular pacing (CRT-on).
Plasma brain natriuretic peptide (BNP) levels were
measured at 1, 3 and 12 months after installment of
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CRT. Oxygen consumption was measured by the
mono-exponential clearance rate of 11C-acetate
(Kmono) for both CRT-off and CRT-on. Cardiac
efficiency was determined using the work metabolic
index (WMI), which was calculated as WMI =
(stroke volume index) 9 (systolic blood pressure) 9
(heart rate)/Kmono. Two groups of patients were
discerned: 14 patients with improved cardiac effi-
ciency and six patients with deteriorated cardiac
efficiency by CRT-on. The mono-exponential clear-
ance rate of 11C-acetate decreased significantly by
CRT-on in the improved cardiac efficiency group, but
increased in the deteriorated- cardiac efficiency
group. At 1-year follow-up, there were significantly
higher rates of major cardiac adverse events in
the deteriorated cardiac efficiency group than in the
improved-cardiac efficiency group. Consequently, the
decrease in oxygen consumption in the early period
after CRT is a useful marker for predicting a good
clinical outcome after CRT. The most impressive
result of the study was that the patients with
improved cardiac efficiency showed decreased oxygen
consumption indicating improved oxidative metabo-
lism with no changes in hemodynamic parameters in
the early period after CRT. The authors concluded that
improvement of cardiac efficiency, as assessed by
11C-acetate PET in the early period after CRT, was
produced by the decrease in oxygen consumption in
patients showing good responses to CRT.
There are several caveats to the study, already
recognized by the authors. Because of the relatively
small population studied (20 patients), the authors were
not able to address differences between non-ischemic
(NICM) and ischemic (ICM) patients. These differ-
ences might be of importance, since Lindner et al. [60]
showed that in patients with NICM CRT induces
changes of myocardial oxygen consumption and
myocardial blood flow on a regional level with a more
uniform distribution between the myocardial walls and
improved ventricular efficiency than in patients with
ICM. Therefore, CRT might to be more effective in
NICM than in ICM patients. Marsan et al. [61]
questioned whether sequential biventricular pacing
provides substantial benefits over conventional simul-
taneous stimulation, particularly regarding the differ-
ences between ICM and NICM patients. It was found
that optimized sequential biventricular pacing further
increased left ventricular systolic performance as
compared to simultaneous stimulation; this finding
held in particular for ICM patients where the presence
of a large scar was correlated with a larger left
ventricular pre-activation. So, ICIM and NICM
patients should be separately considered in the eval-
uation of the effects of CRT therapy. Next, the PET
studies were performed only once in the early period
after CRT and not in the chronic phase. Comparison of
PET data between acute and chronic phases may have
more clearly shown the clinical use of PET to predict
patient responses to CRT. However, the present results
provide new information by showing that improved
cardiac efficiency due to decreased oxygen metabo-
lism may predict the improvement of cardiac function
assessed by plasma BNP levels as well as predicting
major adverse cardiac events after CRT.
To summarize, the study by Kitaizumi et al. [59]
clearly shows that improvement of cardiac efficiency
assessed by 11C-acetate PET in the early period after
CRT is caused by a decrease in oxygen consumption
in patients who showed an adequate response to CRT.
The decrease in oxygen consumption assessed by
PET in the early period after CRT is therefore a
potential marker to predict improvement of cardiac
function and major cardiac events during the first
year of follow-up. More metabolic cardiac studies are
needed to unravel the basic mechanisms of left
ventricular dyssynchrony in order to install the most
appropriate therapy [62, 63].
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